Skip Main Navigation
Page Content

Save This Event

Event Saved

Legal & Tax Considerations for Life Sciences Companies Licensing Technology


Thursday, May 30, 2019 from 8:15 AM to 10:15 AM (EDT)

Ticket Information

Type End Quantity
RSVP May 30, 2019 Free  

Share Legal & Tax Considerations for Life Sciences Companies Licensing Technology

Event Details

Registration and Networking: 8:15 to 8:30am. Arrive early for a continental breakfast and an opportunity to meet your peers.


Licensing Agreements - (Robinson & Cole LLP)

  • Economics of the Deal - Getting the right return on your IP & Technology
  • How to be Nimble – Negotiating for Flexibility (or Restrictions) in your licenses
  • Anticipating a Divorce – Provisions to control for success as well as failure including bankruptcy, dispute resolution, and failure to commercialize.
  • Risk Management – The most important provisions for controlling risk and containing liability.
  • Hot (and sometimes hidden) Issues – What to do about residual know-how, use of data, research samples, and improvements on IP & Technology.

Tax and Accounting Considerations-(CohnReznick LLP)

  • Revenue Recognition Considerations-Nature of the Income
    1. Ordinary Income or Capital Gain-Treatment of Upfront fees, Milestone Payments, Royalties and Deferred Income
    2. C Corporations and S Corporations-Tax treatment under each type
  • New Revenue Standard, including its applicability to collaborative arrangements and the sale of IP

Case Study - Arvinas Inc.

Hear from Arvinas, Inc., (Nasdaq ARVN), a New Haven Bio-pharma whose protein degraders target cancer and a wide range of other diseases. Its Chief Financial Officer, Sean Cassidy, will discuss its partnerships with two well-known pharmaceuticals/biotechs and its negotiations for multi-year strategic license agreements and research collaborations. 



  Jacqueline Scheib, Partner, Robinson & Cole

Jacqueline Pennino Scheib is a Partner with the law firm of Robinson & Cole LLP where she chairs the firm's Intellectual Property and Technology Law Group. With over 20 years in practice, Jackie’s principal areas of concentration include:

  • Counseling on and negotiation of intellectual property and technology licensing and development, including in the context of medical devices, healthcare, implementation of electronic medical record systems and health information exchange platforms.
  • Advising on and structuring mechanisms for the creation, exploitation, transfer and protection of intellectual property and technology worldwide.
  • Counseling on all aspects of clinical trials and scientific/medical research, including strategic alliances for development and exploitation of new technologies and intellectual property, revision and negotiation of clinical trial agreements, research protocols, material transfer agreements, facilities agreements, and grant agreements and advice regarding compliance requirements associated with research activities.

Jackie holds a J.D. from the University of Connecticut Law School and a B.A. in Experimental Psychology from Franklin & Marshall College. Ms. Scheib has been listed in The Best Lawyers in America® in the area of Trademark Law since 2012 and in the area of Copyright Law since 2015. Ms. Scheib is a former clerk for the Connecticut Supreme Court.


  Alex Morgan, CPA, Partner, CohnReznick

Alex Morgan is a partner in CohnReznick’s Tax Practice with more than 20 years of experience serving both publicly traded and privately held companies ranging in size from pre-revenue, start-up businesses to global companies with over $2.0 billion in revenues. Alex’s areas of focus include tax planning and consulting, federal and state tax compliance, and ASC 740 (accounting for income taxes). His expertise extends to specialty areas related to organizational restructuring, business acquisitions and dispositions, due diligence, tax credits and incentives, IRS examination assistance, and international operations.

Alex has extensive knowledge in financial statement accounting and a comprehensive understanding of federal, state, and international tax laws. Alex’s career spans 10 years with Big Four firms and more recently with a Connecticut-based regional firm where he was Partner, Tax Services.

 Guerganagana Rangatcheva, Senior Audit Manager, CohnReznick

Guergana Rangatcheva is a senior audit manager at CohnReznick. She is a key member of the firm’s Technology and Life Sciences Industry Practice in its New England offices. She has served a variety of clients ranging from public companies to privately owned and PE-backed companies in the technology, life sciences, manufacturing and health care industries. Guergana has extensive experience assisting clients with SEC filings and leading and managing audit engagements.

Guergana also provides clients with expertise in complex reporting and accounting matters such as SEC registrations, business combinations, debt and equity financing and stock-based compensation as well as with the adoption of new accounting standards.


 Sean Cassidy, Chief Financial Officer, Arvinas

Mr. Cassidy is the Chief Financial Officer of Arvinas. He has over 20 years of experience in the life sciences industry, including serving as Chief Financial Officer of Axerion Therapeutics, a preclinical biotechnology company developing therapies for neurological diseases and injuries; Chief Financial Officer of CuraGen Corporation (NASDAQ: CRGN), a clinical stage biopharmaceutical company; and Director and Controller of 454 Life Sciences Corporation, a life sciences company that developed and commercialized next generation DNA sequencing instruments and reagents.

Earlier in his career, Mr. Cassidy served at Deloitte, one of the big four public accounting firms with a broad base of clients in the healthcare space. Mr. Cassidy is also the Treasurer of the Friends of Yale New Haven Children’s Hospital, a nonprofit organization that helps improve the health and well-being of pediatric patients and their families.







Have questions about Legal & Tax Considerations for Life Sciences Companies Licensing Technology? Contact BioCT

Save This Event

Event Saved

When & Where

Digital Surgeons
470 James Street
#Suite 1
New Haven, CT 06513

Thursday, May 30, 2019 from 8:15 AM to 10:15 AM (EDT)

  Add to my calendar



BioCT is the bioscience industry voice for the state of Connecticut.  BioCT is dedicated to growing the vibrant bioscience ecosystem in Connecticut by supporting innovation, collaboration, networking, education, talent engagement and advocacy.  We bring together companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people, to create a thriving community to improve patients’ lives and public health. 

  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.